Sellner, L <br/><br/>
Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMT.  [electronic resource] 

 -  Bone marrow transplantation  02 2016 
 - 212-218 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2015.273  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Autografts<br/>Carmustine--administration & dosage<br/>Cytarabine--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Lymphoma--mortality<br/>Male<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Podophyllotoxin--administration & dosage<br/>Registries<br/>Retrospective Studies<br/>Stem Cell Transplantation<br/>Survival Rate<br/>Thiotepa--administration & dosage